Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Schiff

Showing results (371-380 of 424) with videos related to

Pageof 43
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 27, 2004
Prediction of sustained virological response in liver transplant recipients with recurrent hepatitis C virus following combination pegylated interferon alfa-2b and ribavirin therapy using tissue hepatitis C virus reverse transcriptase polymerase chain reaction testingGuy W Neff, Christopher B O'Brien, Robert Cirocco, et al.
Journal of the National Cancer Institute|December 7, 2000
Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivoR Schiff, P Reddy, M Ahotupa, et al.
Journal of Viral Hepatitis|December 22, 1999
Thymosin alpha1 treatment of chronic hepatitis B: results of a phase III multicentre, randomized, double-blind and placebo-controlled studyM G Mutchnick, K L Lindsay, E R Schiff, et al.
Journal of Clinical Gastroenterology|February 25, 2010
Histologic evidence of active liver injury in chronic hepatitis B patients with normal range or minimally elevated alanine aminotransferase levelsKe-Qin Hu, Eugene R Schiff, Kris V Kowdley, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 15, 2010
Long-term treatment with entecavir induces reversal of advanced fibrosis or cirrhosis in patients with chronic hepatitis BEugene R Schiff, Samuel S Lee, You-Chen Chao, et al.
Journal of Hepatology|November 20, 2012
Improved inflammatory activity with peginterferon alfa-2b maintenance therapy in non-cirrhotic prior non-responders: a randomized studyThierry Poynard, Jordi Bruix, Eugene R Schiff, et al.
American Journal of Clinical Oncology|August 10, 1999
A phase I study of chemoembolization with cisplatin, thiotepa, and lipiodol for primary and metastatic liver cancerL G Feun, K R Reddy, T Scagnelli, et al.
Gastroenterology & Hepatology|October 1, 2011
Prospective Evaluation of FIBROSpect II for Fibrosis Detection in Hepatitis C and B Patients Undergoing Laparoscopic BiopsyLennox J Jeffers, Rafael A Cortes, Pablo A Bejarano, et al.
Transplantation|November 19, 2004
Treatment of established recurrent hepatitis C in liver-transplant recipients with pegylated interferon-alfa-2b and ribavirin therapyGuy W Neff, Marzia Montalbano, Christopher B O'Brien, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 13, 2003
A retrospective review of sirolimus (Rapamune) therapy in orthotopic liver transplant recipients diagnosed with chronic rejectionGuy W Neff, Marzia Montalbano, Gabriel Slapak-Green, et al.
Pageof 43

Showing results (371-380 of 424) with videos related to

Sort By:
Pageof 43
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 27, 2004
Prediction of sustained virological response in liver transplant recipients with recurrent hepatitis C virus following combination pegylated interferon alfa-2b and ribavirin therapy using tissue hepatitis C virus reverse transcriptase polymerase chain reaction testingGuy W Neff, Christopher B O'Brien, Robert Cirocco, et al.
Journal of the National Cancer Institute|December 7, 2000
Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivoR Schiff, P Reddy, M Ahotupa, et al.
Journal of Viral Hepatitis|December 22, 1999
Thymosin alpha1 treatment of chronic hepatitis B: results of a phase III multicentre, randomized, double-blind and placebo-controlled studyM G Mutchnick, K L Lindsay, E R Schiff, et al.
Journal of Clinical Gastroenterology|February 25, 2010
Histologic evidence of active liver injury in chronic hepatitis B patients with normal range or minimally elevated alanine aminotransferase levelsKe-Qin Hu, Eugene R Schiff, Kris V Kowdley, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 15, 2010
Long-term treatment with entecavir induces reversal of advanced fibrosis or cirrhosis in patients with chronic hepatitis BEugene R Schiff, Samuel S Lee, You-Chen Chao, et al.
Journal of Hepatology|November 20, 2012
Improved inflammatory activity with peginterferon alfa-2b maintenance therapy in non-cirrhotic prior non-responders: a randomized studyThierry Poynard, Jordi Bruix, Eugene R Schiff, et al.
American Journal of Clinical Oncology|August 10, 1999
A phase I study of chemoembolization with cisplatin, thiotepa, and lipiodol for primary and metastatic liver cancerL G Feun, K R Reddy, T Scagnelli, et al.
Gastroenterology & Hepatology|October 1, 2011
Prospective Evaluation of FIBROSpect II for Fibrosis Detection in Hepatitis C and B Patients Undergoing Laparoscopic BiopsyLennox J Jeffers, Rafael A Cortes, Pablo A Bejarano, et al.
Transplantation|November 19, 2004
Treatment of established recurrent hepatitis C in liver-transplant recipients with pegylated interferon-alfa-2b and ribavirin therapyGuy W Neff, Marzia Montalbano, Christopher B O'Brien, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 13, 2003
A retrospective review of sirolimus (Rapamune) therapy in orthotopic liver transplant recipients diagnosed with chronic rejectionGuy W Neff, Marzia Montalbano, Gabriel Slapak-Green, et al.
Pageof 43